
Werewolf Therapeutics fell 3.1% from $0.98 to $0.95, behind the S&P 500's +3.2%. Its worst day was Dec 18 (−39.6%), and its low came Jun 29 at $0.31.
Nov 24, 2025 – Nov 20, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Werewolf Therapeutics closed at its highest level of the year, 12.6% above where the year started.
+0.9% · S&P 500 −1.1%
EPS of $-0.20 beat the $-0.34 estimate on $0.00 revenue (est. $600,000.00).
Story events cover the past 12 months · Times ET
−9.5% · S&P 500 −1.7%
EPS of $-0.28 beat the $-0.30 estimate on $0.00 revenue.
+9.7% · S&P 500 +0.8%
Werewolf Therapeutics closed at its lowest level of the year, 68.5% below where the year started.
−4.6% · S&P 500 +1.6%
EPS of $0.08 beat the $-0.31 estimate on $21.0M revenue.
−29.4% · S&P 500 +0.7%
Werewolf Therapeutics shares rose 102.6%, while the S&P 500 rose 0.4%.
+102.6%, the year's best day, on 297M shares, the year's heaviest volume · S&P 500 +0.4%
EPS of $-0.20 beat the $-0.22 estimate on $0.00 revenue.
+1.1% · S&P 500 −1.9%
Where it ended: a close of $0.95 on Nov 20, 2026.
Nothing in the past 12 months.
All HOWL dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for HOWL and SPY from Benzinga historical bars. Not investment advice.